This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2009 Mar 23:338:b1223.

doi: 10.1136/bmj.b1223.

Experimental vaccine may have saved Hamburg scientist from Ebola fever

PMID: 19307268
DOI: 10.1136/bmj.b1223

Case Reports

Experimental vaccine may have saved Hamburg scientist from Ebola fever

Annette Tuffs. BMJ. 2009.

. 2009 Mar 23:338:b1223.

doi: 10.1136/bmj.b1223.

Author

PMID: 19307268
DOI: 10.1136/bmj.b1223

No abstract available

PubMed Disclaimer

Similar articles

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.
Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Ströher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschläger S, Schmidt-Chanasit J, Sudeck H, Burchard GD, Schmiedel S. Günther S, et al. J Infect Dis. 2011 Nov;204 Suppl 3:S785-90. doi: 10.1093/infdis/jir298. J Infect Dis. 2011. PMID: 21987751
Emergency treatment for exposure to Ebola virus: the need to fast-track promising vaccines.
Geisbert TW. Geisbert TW. JAMA. 2015 Mar 24-31;313(12):1221-2. doi: 10.1001/jama.2015.2057. JAMA. 2015. PMID: 25742306 No abstract available.
A DNA vaccine for the prevention of Ebola virus infection.
Dery M, Bausch DG. Dery M, et al. Curr Opin Mol Ther. 2008 Jun;10(3):285-93. Curr Opin Mol Ther. 2008. PMID: 18535936
Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
Bausch DG, Sprecher AG, Jeffs B, Boumandouki P. Bausch DG, et al. Antiviral Res. 2008 Apr;78(1):150-61. doi: 10.1016/j.antiviral.2008.01.152. Epub 2008 Feb 26. Antiviral Res. 2008. PMID: 18336927 Review.
[Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E, Baize S, Gonzalez JP. Leroy E, et al. Med Trop (Mars). 2011 Apr;71(2):111-21. Med Trop (Mars). 2011. PMID: 21695865 Review. French.

See all similar articles

Cited by

Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.
Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala J, Yoti Z, Colebunders R, Palma PP, Sterk E, Jeffs B, Van Herp M, Borchert M. Roddy P, et al. PLoS One. 2012;7(12):e52986. doi: 10.1371/journal.pone.0052986. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285243 Free PMC article.
Ebola vaccines in clinical trial: The promising candidates.
Wang Y, Li J, Hu Y, Liang Q, Wei M, Zhu F. Wang Y, et al. Hum Vaccin Immunother. 2017 Jan 2;13(1):153-168. doi: 10.1080/21645515.2016.1225637. Epub 2016 Oct 20. Hum Vaccin Immunother. 2017. PMID: 27764560 Free PMC article. Review.
Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW, Bausch DG, Feldmann H. Geisbert TW, et al. Rev Med Virol. 2010 Nov;20(6):344-57. doi: 10.1002/rmv.661. Rev Med Virol. 2010. PMID: 20658513 Free PMC article. Review.
Animal models for Ebola and Marburg virus infections.
Nakayama E, Saijo M. Nakayama E, et al. Front Microbiol. 2013 Sep 5;4:267. doi: 10.3389/fmicb.2013.00267. Front Microbiol. 2013. PMID: 24046765 Free PMC article. Review.
Ebolavirus glycoprotein structure and mechanism of entry.
Lee JE, Saphire EO. Lee JE, et al. Future Virol. 2009;4(6):621-635. doi: 10.2217/fvl.09.56. Future Virol. 2009. PMID: 20198110 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information